Browsing Tag
Avexitide
1 post
Amylyx (Nasdaq: AMLX) upsizes offering to $500m as avexitide advances
The biotechnology company is selling 14.09 million shares at $35.50 after avexitide cut severe hypoglycemic events by 55% in pivotal Phase 3 testing.